A citation-based method for searching scientific literature


List of co-cited articles
107 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery?
Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, Andrea Milelli. J Med Chem 2021
24
20

The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
Ratan V Bhat, Ulf Andersson, Shalini Andersson, Laurent Knerr, Udo Bauer, Anna K Sundgren-Andersson. J Alzheimers Dis 2018
48
20


Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
Eleonore Beurel, Steven F Grieco, Richard S Jope. Pharmacol Ther 2015
871
20


Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
Philip T T Ly, Yili Wu, Haiyan Zou, Ruitao Wang, Weihui Zhou, Ayae Kinoshita, Mingming Zhang, Yi Yang, Fang Cai, James Woodgett,[...]. J Clin Invest 2013
256
15

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.
Guy Griebel, Jeanne Stemmelin, Mati Lopez-Grancha, Denis Boulay, Gerald Boquet, Franck Slowinski, Philippe Pichat, Sandra Beeské, Shinji Tanaka, Akiko Mori,[...]. Sci Rep 2019
40
15

GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration.
Tomasz Jaworski, Ewa Banach-Kasper, Katarzyna Gralec. Neural Plast 2019
50
15

GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib.
Junyu Li, Shanshan Ma, Jingnan Chen, Kunhua Hu, Yongyi Li, Zeyu Zhang, Zixiang Su, James R Woodgett, Mingtao Li, Qiaoying Huang. Front Mol Neurosci 2020
19
15



Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Mojtaba Golpich, Elham Amini, Fatemeh Hemmati, Norlinah Mohamed Ibrahim, Behrouz Rahmani, Zahurin Mohamed, Azman Ali Raymond, Leila Dargahi, Rasoul Ghasemi, Abolhassan Ahmadiani. Pharmacol Res 2015
167
15

Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis.
Daniel A Linseman, Brent D Butts, Thomas A Precht, Reid A Phelps, Shoshona S Le, Tracey A Laessig, Ron J Bouchard, Maria L Florez-McClure, Kim A Heidenreich. J Neurosci 2004
310
15

Structure of GSK3beta reveals a primed phosphorylation mechanism.
E ter Haar, J T Coll, D A Austen, H M Hsiao, L Swenson, J Jain. Nat Struct Biol 2001
285
15

LTP inhibits LTD in the hippocampus via regulation of GSK3beta.
Stéphane Peineau, Changiz Taghibiglou, Clarrisa Bradley, Tak Pan Wong, Lidong Liu, Jie Lu, Edmond Lo, Dongchuan Wu, Emilia Saule, Tristan Bouschet,[...]. Neuron 2007
539
15

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
K P Hoeflich, J Luo, E A Rubie, M S Tsao, O Jin, J R Woodgett. Nature 2000
15

GSK3: A Kinase Balancing Promotion and Resolution of Inflammation.
Leonie Hoffmeister, Mareike Diekmann, Korbinian Brand, René Huber. Cells 2020
47
15

Glycogen Synthase Kinase 3: A Kinase for All Pathways?
Prital Patel, James R Woodgett. Curr Top Dev Biol 2017
126
15

Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.
Luca Busino, Scott E Millman, Luigi Scotto, Christos A Kyratsous, Venkatesha Basrur, Owen O'Connor, Alexander Hoffmann, Kojo S Elenitoba-Johnson, Michele Pagano. Nat Cell Biol 2012
138
15

Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
Rana Dajani, Elizabeth Fraser, S Mark Roe, Maggie Yeo, Valerie M Good, Vivienne Thompson, Trevor C Dale, Laurence H Pearl. EMBO J 2003
229
15


Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Manuela Neumann, Deepak M Sampathu, Linda K Kwong, Adam C Truax, Matthew C Micsenyi, Thomas T Chou, Jennifer Bruce, Theresa Schuck, Murray Grossman, Christopher M Clark,[...]. Science 2006
10

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.
Jemeen Sreedharan, Ian P Blair, Vineeta B Tripathi, Xun Hu, Caroline Vance, Boris Rogelj, Steven Ackerley, Jennifer C Durnall, Kelly L Williams, Emanuele Buratti,[...]. Science 2008
10

Recent Advances on the Role of GSK3β in the Pathogenesis of Amyotrophic Lateral Sclerosis.
Hyun-Jun Choi, Sun Joo Cha, Jang-Won Lee, Hyung-Jun Kim, Kiyoung Kim. Brain Sci 2020
12
16

ALS/FTD-associated FUS activates GSK-3β to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations.
Radu Stoica, Sébastien Paillusson, Patricia Gomez-Suaga, Jacqueline C Mitchell, Dawn Hw Lau, Emma H Gray, Rosa M Sancho, Gema Vizcay-Barrena, Kurt J De Vos, Christopher E Shaw,[...]. EMBO Rep 2016
159
10

Disruption of ER-mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis.
Dawn H W Lau, Naomi Hartopp, Natalie J Welsh, Sarah Mueller, Elizabeth B Glennon, Gábor M Mórotz, Ambra Annibali, Patricia Gomez-Suaga, Radu Stoica, Sebastien Paillusson,[...]. Cell Death Dis 2018
39
10

p38 kinase is activated in the Alzheimer's disease brain.
K Hensley, R A Floyd, N Y Zheng, R Nael, K A Robinson, X Nguyen, Q N Pye, C A Stewart, J Geddes, W R Markesbery,[...]. J Neurochem 1999
285
10


Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.
Orestes V Forlenza, Breno S Diniz, Márcia Radanovic, Franklin S Santos, Leda L Talib, Wagner F Gattaz. Br J Psychiatry 2011
226
10

The role of GSK-3 in synaptic plasticity.
S Peineau, C Bradley, C Taghibiglou, A Doherty, Z A Bortolotto, Y T Wang, G L Collingridge. Br J Pharmacol 2008
200
10

Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease.
Marta Fernández-Nogales, Félix Hernández, Andrés Miguez, Jordi Alberch, Silvia Ginés, Esther Pérez-Navarro, José J Lucas. Hum Mol Genet 2015
27
10

The Sleep Side of Aging and Alzheimer's Disease.
S M Romanella, D Roe, E Tatti, D Cappon, R Paciorek, E Testani, A Rossi, S Rossi, E Santarnecchi. Sleep Med 2021
10
20

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
10


The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
10

Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Nicole Maphis, Shanya Jiang, Guixiang Xu, Olga N Kokiko-Cochran, Saktimayee M Roy, Linda J Van Eldik, D Martin Watterson, Bruce T Lamb, Kiran Bhaskar. Alzheimers Res Ther 2016
65
10



Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
J A McCubrey, L S Steelman, F E Bertrand, N M Davis, S L Abrams, G Montalto, A B D'Assoro, M Libra, F Nicoletti, R Maestro,[...]. Leukemia 2014
182
10

Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.
K Hughes, E Nikolakaki, S E Plyte, N F Totty, J R Woodgett. EMBO J 1993
501
10

A phase II trial of tideglusib in Alzheimer's disease.
Simon Lovestone, Mercè Boada, Bruno Dubois, Michael Hüll, Juha O Rinne, Hans-Jürgen Huppertz, Miguel Calero, María V Andrés, Belén Gómez-Carrillo, Teresa León,[...]. J Alzheimers Dis 2015
261
10


Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability.
Francesca Demarchi, Cosetta Bertoli, Peter Sandy, Claudio Schneider. J Biol Chem 2003
133
10

Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.
Florence F Wagner, Lina Benajiba, Arthur J Campbell, Michel Weïwer, Joshua R Sacher, Jennifer P Gale, Linda Ross, Alexandre Puissant, Gabriela Alexe, Amy Conway,[...]. Sci Transl Med 2018
55
10

GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity.
Takeshi Yoshimura, Yoji Kawano, Nariko Arimura, Saeko Kawabata, Akira Kikuchi, Kozo Kaibuchi. Cell 2005
714
10

The GSK3 hypothesis of Alzheimer's disease.
Claudie Hooper, Richard Killick, Simon Lovestone. J Neurochem 2008
800
10

GSK3 and its interactions with the PI3K/AKT/mTOR signalling network.
Miguel A Hermida, J Dinesh Kumar, Nick R Leslie. Adv Biol Regul 2017
210
10

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.
Michael Martin, Kunal Rehani, Richard S Jope, Suzanne M Michalek. Nat Immunol 2005
866
10

Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease.
Rita Maria Concetta Di Martino, Letizia Pruccoli, Alessandra Bisi, Silvia Gobbi, Angela Rampa, Ana Martinez, Concepción Pérez, Loreto Martinez-Gonzalez, Maria Paglione, Elia Di Schiavi,[...]. ACS Chem Neurosci 2020
20
10

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.
X Fang, S X Yu, Y Lu, R C Bast, J R Woodgett, G B Mills. Proc Natl Acad Sci U S A 2000
606
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.